Impact of pathologic complete response on disease-free survival in patients with esophagogastric adenocarcinoma receiving preoperative docetaxel-based chemotherapy.
about
ESOPEC: prospective randomized controlled multicenter phase III trial comparing perioperative chemotherapy (FLOT protocol) to neoadjuvant chemoradiation (CROSS protocol) in patients with adenocarcinoma of the esophagus (NCT02509286).Complete pathological response following neoadjuvant FOLFIRINOX in borderline resectable pancreatic cancer - a case report and reviewThe relationship between pathologic nodal disease and residual tumor viability after induction chemotherapy in patients with locally advanced esophageal adenocarcinoma receiving a tri-modality regimenMetastatic Gastroesophageal Adenocarcinoma Patients Treated with Systemic Therapy Followed by Consolidative Local Therapy: A Nomogram Associated with Long-Term SurvivorsPhase II study of neo-adjuvant chemotherapy for locally advanced gastric cancer.Docetaxel, Cisplatin, and 5-Fluorouracil as perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma.Phase II study of neoadjuvant therapy with nab-paclitaxel and cisplatin followed by surgery in patients with locally advanced esophageal squamous cell carcinomaPathological Complete Remission of Pancreatic Cancer Following Neoadjuvant Chemoradiation Therapy; Not the End of Battles.Complete Response after Treatment with Neoadjuvant Chemoradiation with Prolonged Chemotherapy for Locally Advanced, Unresectable Adenocarcinoma of the Pancreas.Long-term survival outcomes of advanced gastric cancer patients who achieved a pathological complete response with neoadjuvant chemotherapy: a systematic review of the literature.Association of Clinical Factors With a Major Pathologic Response Following Preoperative Therapy for Pancreatic Ductal Adenocarcinoma.A network meta-analysis of the short-term efficacy of five chemotherapy regimens based on cisplatin and fluorouracil for esophagogastric junctional adenocarcinoma.Evaluation of Anastomotic Leak after Esophagectomy for Esophageal Cancer: Typical Time Point of Occurrence, Mode of Diagnosis, Value of Routine Radiocontrast Agent Studies and Therapeutic Options.Correlation of pathological complete response with survival after neoadjuvant chemotherapy in gastric or gastroesophageal junction cancer treated with radical surgery: A meta-analysis.Clinicopathological and prognostic significance of high circulating lymphocyte ratio in patients receiving neoadjuvant chemotherapy for advanced gastric cancer.Different accuracy of endosonographic tumor staging after neoadjuvant chemotherapy and chemoradiotherapy in esophageal cancer.Influence of Different Neoadjuvant Chemotherapy Regimens on Response, Prognosis, and Complication Rate in Patients with Esophagogastric Adenocarcinoma.Pathological assessment of resection specimens after neoadjuvant therapy for metastatic melanoma
P2860
Q36082155-EF569174-5952-4C7F-856B-442A90C57056Q36159880-4F24288E-9816-4F2F-B793-A8CE3A7C64A3Q36666677-0A0CAD95-00FD-451A-A63F-40AF08F61A44Q37104321-B5911672-FCD2-49AD-8E36-843EDEF6E92BQ37236380-0B6A7CCD-AB9E-47A5-8684-9559C2E68582Q37429923-996D6EEC-4EFA-4E6E-84FA-627E6B9BD3EBQ37580437-B78EBC92-F4FC-41D9-A861-D164B70DAC97Q37624171-1E56641F-90DD-418C-88CA-7B40496C9CFAQ37714700-92F1B8A6-5962-4C06-9D91-8F6681A6252BQ38249890-FC8C9E68-9F1E-48F7-B643-5F089FDCF76DQ39430849-3548E298-AC7C-4E57-B99A-F10079F32AFBQ42370438-052EA12C-83DD-4AAA-A03D-AFD53F36AE7EQ47609004-F74FE780-DE55-413F-A4BC-4E8BF8104E03Q48166034-B655CFC3-2A82-4860-959D-178FC1DE5581Q52718458-4A7636FD-9325-4921-951F-40EDC2145055Q53304850-D1C38D51-CC0E-4E07-A3A9-8C17D1358D10Q53496643-7EA7C3BC-F114-4B6E-BAA8-A532BF24F67AQ58747486-6DE8D724-4D6C-4200-B1FD-57471067D9E7
P2860
Impact of pathologic complete response on disease-free survival in patients with esophagogastric adenocarcinoma receiving preoperative docetaxel-based chemotherapy.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Impact of pathologic complete ...... docetaxel-based chemotherapy.
@en
Impact of pathologic complete ...... docetaxel-based chemotherapy.
@nl
type
label
Impact of pathologic complete ...... docetaxel-based chemotherapy.
@en
Impact of pathologic complete ...... docetaxel-based chemotherapy.
@nl
prefLabel
Impact of pathologic complete ...... docetaxel-based chemotherapy.
@en
Impact of pathologic complete ...... docetaxel-based chemotherapy.
@nl
P2093
P2860
P356
P1433
P1476
Impact of pathologic complete ...... e docetaxel-based chemotherapy
@en
P2093
G Schumacher
P Thuss-Patience
S E Al-Batran
S Lorenzen
T Schuster
P2860
P304
P356
10.1093/ANNONC/MDT141
P577
2013-04-16T00:00:00Z